ஜநரல் ஊட்டச்சத்து நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜநரல் ஊட்டச்சத்து நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜநரல் ஊட்டச்சத்து நிறுவனம் Today - Breaking & Trending Today

Natural Alternatives International, Inc. Announces 2021 Q4 and YTD Results

Natural Alternatives International, Inc. Announces 2021 Q4 and YTD Results
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Michael Fortin , Marka Le , Tufts University In Healthcare Innovation Management , Prnewswire Natural Alternatives International Inc , Natural Alternatives International Inc , Exchange Commission , Natural Products Association , Securities Exchange , Safety Compliance Initiative , Nutrition Corporation , Duke University Fuqua School Of Business , Alternatives International , Guru Ramanathan , Chief Innovation Officer , General Nutrition Corporation , Supplement Safety , Compliance Initiative , Tufts University , Healthcare Innovation Management , Duke University Fuqua School , Chief Executive Officer , Supplement Safety Compliance Initiative , Securities Exchange Act , Annual Report , Chief Financial Officer ,

Protein Supplement Market to manifest the fastest CAGR of 7.4% through 2025

Protein Supplement Market to manifest the fastest CAGR of 7.4% through 2025
texasguardian.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from texasguardian.com Daily Mail and Mail on Sunday newspapers.

United States , Hong Kong , United Kingdom , David Correa , Age Group , Holdings Inc , Glaxosmithkline Plc , Semiconductor Electronics , Maker Nutrition , Energy Power , Aerospace Defense , Research Newswire , Nutrition Corporation , Herbalife International Of America Inc , Business Intelligence Solutions , Glambia Plc , Vitaco Health , Market Research , See Campaign , Life Sciences , Pharma Inc , Abbott Laboratories , Allied Market Research , Supplement Market , Distribution Channel , Global Opportunity Analysis ,

Protein Supplement Market to manifest the fastest CAGR of 7.4% through 2025

Protein Supplement Market to manifest the fastest CAGR of 7.4% through 2025
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.

United States , Hong Kong , United Kingdom , David Correa , Age Group , Holdings Inc , Glaxosmithkline Plc , Semiconductor Electronics , Maker Nutrition , Energy Power , Aerospace Defense , Research Newswire , Nutrition Corporation , Herbalife International Of America Inc , Business Intelligence Solutions , Glambia Plc , Vitaco Health , Market Research , See Campaign , Life Sciences , Pharma Inc , Abbott Laboratories , Allied Market Research , Supplement Market , Distribution Channel , Global Opportunity Analysis ,

Cardax Reports Q1 2021 Results

Cardax Reports Q1 2021 Results
- Operating loss decreased vs. Q1 2020
- Net loss increased vs. Q1 2020
- ZanthoSyn® revenues decreased vs. Q1 2020
- Company pursuing multiple funding opportunities
News provided by
Share this article
HONOLULU, May 14, 2021 /PRNewswire/ Cardax, Inc. (OTCQB:CDXI) reported its Q1 2021 results. Highlights:
Financial Results. Operating loss decreased from $906,031 in Q1 2020 to $771,312 in Q1 2021 primarily due to reduced salaries & wages, professional fees, stock based compensation, and selling, general, & administrative expenses. Other expenses increased from $96,837 in Q1 2020 to $610,806 in Q1 2021, primarily due to a non-cash reduction in the gain from modification of debt instruments and a non-cash change in the fair value of the derivative liability. Net loss increased from $1,002,868 in Q1 2020 to $1,382,118 in Q1 2021. ....

United States , Davidg Watumull , Janice Kam , Exchange Commission , Cardax Inc , Small Business Administration Economic Injury Disaster Loan , Drug Administration , Securities Exchange , Nutrition Corporation , Cardiovascular Health Astaxanthin Supplement Evaluation , General Nutrition Corporation , Small Business Administration , Economic Injury Disaster Loan , Quarterly Report , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் , ஜானிஸ் கம் , பரிமாற்றம் தரகு , பத்திரங்கள் பரிமாற்றம் , ஊட்டச்சத்து நிறுவனம் , ஜநரல் ஊட்டச்சத்து நிறுவனம் , பொருளாதார காயம் பேரழிவு கடன் , காலாண்டு அறிக்கை , பத்திரங்கள் நாடகம் ,

Cardax Reports 2020 Results

Cardax Reports 2020 Results
- ZanthoSyn® revenues decreased vs. 2019
- Company pursuing multiple funding opportunities
- CHASE study recruitment suspended due to COVID-19
- COVID-19 clinical trial grant application progresses
News provided by
Share this article
HONOLULU, April 15, 2021 /PRNewswire/ Cardax, Inc. (OTCQB:CDXI) reported its 2020 results. Highlights:
Financial Results. Net loss for 2020 decreased from $5,093,037 in 2019 to $5,055,507 in 2020. Operating expenses decreased from $4,442,659 in 2019 to $3,405,452 in 2020, primarily due to reduced professional fees, research & development, salaries & wages, and selling, general, & administrative expenses. Other expenses increased from $1,015,934 in 2019 to $1,992,871 in 2020, primarily due to non-cash debt discounts related to outstanding convertible notes.
ZanthoSyn® Sales. Cardax net revenues from ZanthoSyn®, the Company s astaxanthin dietary supplement, decreased from $710,949 in ....

United States , Janice Kam , Davidg Watumull , Exchange Commission , Cardax Inc , Drug Administration , Securities Exchange , Nutrition Corporation , Cardiovascular Health Astaxanthin Supplement Evaluation , General Nutrition Corporation , Trial Grant , Annual Report , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் , ஜானிஸ் கம் , பரிமாற்றம் தரகு , பத்திரங்கள் பரிமாற்றம் , ஊட்டச்சத்து நிறுவனம் , ஜநரல் ஊட்டச்சத்து நிறுவனம் , சோதனை மானியம் , ஆண்டு அறிக்கை , பத்திரங்கள் நாடகம் , பத்திரங்கள் பரிமாற்றம் நாடகம் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் ,